An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1998-07-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.95.14.7866PMID 9653106PMCID PMC20895
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity

  1998cited by this paper
• Leptin gene therapy and daily protein administration: a comparative study in the ob/ob mouse

  1998cited by this paper
• Construction of adenovirus vectors through Cre-lox recombination

  1997cited by this paper
• Immune Responses to Adenoviral Vectors During Gene Transfer in the Brain

  1997cited by this paper
• Persistence in muscle of an adenoviral vector that lacks all viral genes.

  1997cited by this paper
• Characterization of Factors Involved in Modulating Persistence of Transgene Expression from Recombinant Adenovirus in the Mouse Lung

  1997cited by this paper
• Humoral immune response to the capsid components of recombinant adenoviruses: Routes of immunization modulate virus‐induced Ig subclass shifts

  1997cited by this paper
• Innate Immune Mechanisms Dominate Elimination of Adenoviral Vectors Following In Vivo Administration

  1997cited by this paper
• A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging

  1997cited by this paper
• Production and characterization of human 293 cell lines expressing the site-specific recombinase Cre

  1996cited by this paper
• Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis.

  1996cited by this paper
• Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo

  1996cited by this paper
• Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice.

  1996cited by this paper
• Correction of obesity and diabetes in genetically obese mice by leptin gene therapy.

  1996cited by this paper
• A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase.

  1996cited by this paper
• A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal.

  1996cited by this paper
• In Vivo Expression of Full-Length Human Dystrophin from Adenoviral Vectors Deleted of All Viral Genes

  1996cited by this paper
• Patient selection may affect gene therapy success. Dominant negative effects observed for ornithine transcarbamylase in mouse and human hepatocytes.

  1996cited by this paper
• Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells.

  1996cited by this paper
• In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes.

  1996cited by this paper
• Immune responses to transgene–encoded proteins limit the stability of gene expression after injection of replication–defective adenovirus vectors

  1996cited by this paper
• Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

  1995cited by this paper
• Weight-reducing effects of the plasma protein encoded by the obese gene.

  1995cited by this paper
• Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks.

  1995cited by this paper
• Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector.

  1995cited by this paper
• Effects of the obese gene product on body weight regulation in ob/ob mice.

  1995cited by this paper
• Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.

  1994cited by this paper
• Adenovirus-Mediated Transfer of the CFTR Gene to Lung of Nonhuman Primates: Biological Efficacy Study

  1993cited by this paper
• Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice.

  1993cited by this paper
• Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes.

  1993cited by this paper
• Hepatic gene therapy: persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery in vivo.

  1992cited by this paper
• Hepatic Gene Therapy: Persistent Expression of Human α1-Antitrypsin in Mice after Direct Gene Delivery In Vivo

  1992cited by this paper
• Manipulation of adenovirus vectors.

  1991cited by this paper
• Evaluation of the Transfer and Expression in Mice of an Enzyme-Encoding Gene Using a Human Adenovirus Vector

  1990cited by this paper
• Molecular cloning : a laboratory manual. Cold Spring Harbor, NY

  1989cited by this paper
• Yeast ARS function and nuclear matrix association coincide in a short sequence from the human HPRT locus

  1988cited by this paper
• Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

  1977cited by this paper

• Gene Editing Therapies Targeting Lipid Metabolism for Cardiovascular Disease: Tools, Delivery Strategies, and Clinical Progress

  2026cites this paper
• Strategies for Modifying Adenoviral Vectors for Gene Therapy

  2024cites this paper
• Clinical and Translational Landscape of Viral Gene Therapies

  2024cites this paper
• Clinical Application of Adenovirus (AdV): A Comprehensive Review

  2024cites this paper
• High-Throughput Screening for the Prevalence of Neutralizing Antibodies against Human Adenovirus Serotype 5

  2024cites this paper
• Preclinical model for phenotypic correction of dystrophic epidermolysis bullosa by in vivo CRISPR-Cas9 delivery using adenoviral vectors

  2022cites this paper
• Locked and loaded: engineering and arming oncolytic adenoviruses to enhance anti-tumor immune responses

  2022cites this paper
• SARS-CoV-2 vaccine ChAdOx1 nCoV-19 infection of human cell lines reveals low levels of viral backbone gene transcription alongside very high levels of SARS-CoV-2 S glycoprotein gene transcription

  2021cites this paper
• Characterization of integration frequency and insertion sites of adenovirus DNA into mouse liver genomic DNA following intravenous injection

  2021influential citation
• Traditional treatment strategies for alcoholism and the withdrawal symptoms

  2021cites this paper
• Chemogenetics drives paradigm change in the investigation of behavioral circuits and neural mechanisms underlying drug action.

  2021cites this paper
• A New Gorilla Adenoviral Vector with Natural Lung Tropism Avoids Liver Toxicity and Is Amenable to Capsid Engineering and Vector Retargeting

  2020cites this paper
• High-Capacity Adenoviral Vectors Permit Robust and Versatile Testing of DMD Gene Repair Tools and Strategies in Human Cells

  2020cites this paper
• SARS-CoV-2 candidate vaccine ChAdOx1 nCoV-19 infection of human cell lines reveals a normal low range of viral backbone gene expression alongside very high levels of SARS-CoV-2 S glycoprotein expression.

  2020cites this paper
• CAV-2 Vector Development and Gene Transfer in the Central and Peripheral Nervous Systems

  2019cites this paper
• Exosomes: A Novel Biomarker and Approach to Gene Therapy for Spinal Muscular Atrophy

  2019cites this paper
• The use of chemogenetics in behavioural neuroscience: receptor variants, targeting approaches and caveats

  2018cites this paper
• Introduction to Gene and Stem-Cell Therapy

  2017cites this paper
• Critical Review of Alcohol, Alcoholism and the Withdrawal Symptoms. II. Treatment Strategies

  2017cites this paper
• Application to Gene Therapy and Vaccination

  2017cites this paper
• Deliverable transgenics & gene therapy possibilities for the testes.

  2017cites this paper
• Therapeutic applications of endothelial progenitor cells for diabetic ulcer healing

  2016cites this paper
• THE USE OF VIRAL VECTORS IN GENE TRANSFER THERAPY

  2016cites this paper
• Novel HDAd/EBV Reprogramming Vector and Highly Efficient Ad/CRISPR-Cas Sickle Cell Disease Gene Correction

  2016cites this paper
• Treating Hemophilia by Gene Therapy

  2016cites this paper
• Chapter 1: Introduction

  2016cites this paper
• zur Erlangung des akademischen Grades Doctor medicinae (Dr. med.)

  2015cites this paper
• Measuring CFTR Function of Lung Epithelial Colonies by Means of Forskolin-Induced Swelling: A Proof of Concept Study

  2015cites this paper
• Engineered retroviral virus-like particles for receptor targeting

  2014cites this paper
• The Adenovirus Genome Contributes to the Structural Stability of the Virion

  2014cites this paper
• Recombinant Pegylated first and third generation adenovirus vectors for delivery of anti-Hepatitis B virus RNA interference effectors

  2014cites this paper
• Breast Cancer Gene Therapy

  2014cites this paper
• Recombinant adenovirus-mediated overexpression of 3β-hydroxysteroid-Δ24 reductase

  2014cites this paper
• Modification to the immunodominant loop of hepatitis B virus core protein to enhance vector properties of virus-like particles

  2014cites this paper
• Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastoma.

  2013cites this paper
• biphasic liver toxicity in hemophilia A dogs results in short-term phenotypic correction, inhibitor development, and Systemic delivery of an adenoviral vector encoding canine factor VIII

  2013cites this paper
• UNIVERSIDADE DE LISBOA FACULDADE DE CIÊNCIAS DEPARTAMENTO DE BIOLOGIA ANIMAL GENERATION AND CHARACTERIZATION OF NOVEL ADENOVIRAL VECTORS FOR HYBRID NUCLEASE- MEDIATED GENE TARGETING SARA

  2013cites this paper
• adenovirus vector restoration of clotting activity in hemophilic mice using a minimal Sustained high-level expression of full-length human factor VIII and

  2013cites this paper
• Nucleic Acids as Therapeutics

  2012cites this paper
• Functional studies on factor VIII variants containing different lengths of the B-domain AND The construction of a new helper vector for the production of helper-dependent

  2012cites this paper
• Genetic targeting of specific neuronal cell types in the cerebral cortex.

  2012cites this paper
• Transient embolization with microspheres of polyhydroxyalkanoate renders efficient adenoviral transduction of pancreatic capillary in vivo

  2012cites this paper
• Gene Therapy for Parkinson’s: Disease from Bench to Bedside

  2012cites this paper
• Delivery Systems for Pulmonary Gene Therapy

  2012cites this paper
• shRNA-induced interferon-stimulated gene analysis.

  2012cites this paper
• Cytokine Protocols

  2012cites this paper
• Viral vectors for gene delivery to the central nervous system.

  2012cites this paper
• New insights into stability of recombinant adenovirus vector genomes in mammalian cells.

  2012cites this paper
• From Nucleic Acids Sequences to Molecular Medicine

  2012cites this paper
• Implications of the innate immune response to adenovirus and adenoviral vectors.

  2011cites this paper
• Adenovirus-mediated gene transfer.

  2011cites this paper
• Neonatal helper-dependent adenoviral vector gene therapy mediates correction of hemophilia A and tolerance to human factor VIII

  2011cites this paper
• Construction and evaluation of high-capacity adenoviral vectors for gene therapy applications

  2011cites this paper
• Strong foreign promoters contribute to innate inflammatory responses induced by adenovirus transducing vectors.

  2011cites this paper
• Gene therapy: light is finally in the tunnel

  2011influential citation
• Retinal ganglion cell gene therapy and visual system repair.

  2011cites this paper
• Adenoviral vector immunity: its implications and circumvention strategies.

  2011cites this paper
• Gene Therapy for Alpha-1-Antitrypsin Deficiency Diseases

  2011cites this paper
• RNAi‐Mediated Therapeutics

  2011cites this paper
• Altering the Ad5 Packaging Domain Affects the Maturation of the Ad Particles

  2011cites this paper
• Neurobiology of Disease

  2011cites this paper
• Subretinal gene delivery using helper-dependent adenoviral vectors

  2011cites this paper
• Adenovirus-retrovirus hybrid vectors achieve highly enhanced tumor transduction and antitumor efficacy in vivo.

  2011cites this paper
• Production of adenovirus vectors and their use as a delivery system for influenza vaccines

  2010cites this paper
• Delivering Large Therapeutic Genes for Muscle Gene Therapy

  2010cites this paper
• Antitumor effect of mSurvivinThr34 → Ala in murine colon carcinoma when administered intravenously

  2010cites this paper
• Leptin gene therapy in the fight against diabetes

  2010influential citation
• Engineered adenovirus serotypes for overcoming anti-vector immunity

  2009cites this paper
• RNA-Interferenz-vermittelte Gentherapie bei Herzinsuffizienz mittels Phospholamban-shRNA exprimierender adenoviraler und AAV–Vektoren

  2009cites this paper
• 293 cell cycle synchronisation adenovirus vector production

  2009cites this paper
• Methods, potentials, and limitations of gene delivery to regenerate central nervous system cells

  2009cites this paper
• Mesenchymal Stem Cells: Applications in Cell and Gene Therapy

  2009cites this paper
• First step in characterization of cis-acting sequences involved in fowl adenovirus 1 (CELO) packaging and its effect on the development of a helper-dependent vector strategy

  2009cites this paper
• Importance of Viruses and Cells in Cancer Gene Therapy

  2009cites this paper
• CHAPTER 53 – Gene Therapy

  2009cites this paper
• DNA as Therapeutics; an Update

  2009cites this paper
• Robust In Vivo Transduction of a Genetically Stable Epstein-Barr Virus Episome to Hepatocytes in Mice by a Hybrid Viral Vector

  2009cites this paper
• Characterization of high‐capacity adenovirus production by the quantitative real‐time polymerase chain reaction: a comparative study of different titration methods

  2008cites this paper
• Periocular triamcinolone enhances intraocular gene expression after delivery by adenovirus.

  2008cites this paper
• Gene Therapy and Vaccination

  2008cites this paper
• Concepts in genetic medicine

  2008cites this paper
• Episomal vectors for gene therapy.

  2008cites this paper
• The immunogenicity of adenovirus vectors limits the multispecificity of CD8 T-cell responses to vector-encoded transgenic antigens.

  2008cites this paper
• Lethality in an anti‐angiogenic tumor gene therapy model upon constitutive but not inducible expression of the soluble vascular endothelial growth factor receptor 1

  2008cites this paper
• Development of a suspension serum-free helper-dependent adenovirus production system and assessment of co-infection conditions.

  2008cites this paper
• Advances in helper-dependent adenoviral vector research.

  2008cites this paper
• Adenoviral gene therapy for non-small cell lung cancer

  2008cites this paper
• Cystic fibrosis, vector-mediated gene therapy, and relevance of toll-like receptors: a review of problems, progress, and possibilities.

  2008cites this paper
• Persistent expression of PEDF in the eye using high-capacity adenovectors.

  2008cites this paper
• Barriers for retinal gene therapy: separating fact from fiction.

  2008cites this paper
• Studies on Sertoli cell function using in vivo and in vitro models

  2008cites this paper
• Helper-dependent Adenovirus-mediated Short Hairpin RNA Expression in the Liver Activates the Interferon Response*

  2008cites this paper
• Gene Therapy for Cystic Fibrosis

  2008cites this paper
• High Transduction Efficiency of Human Amniotic Fluid Stem Cells Mediated by Adenovirus Vectors

  2008cites this paper
• Engineering delivery and release of protein therapeutics for mammalian systems

  2008cites this paper
• Characterisation of a dominant negative androgen receptor in prostate cancer cells.

  2008cites this paper
• Conventional and gene therapy strategies for the treatment of brain tumors.

  2008cites this paper
• Efficacy of helper-dependent adenovirus vector-mediated gene therapy in murine glycogen storage disease type Ia.

  2007cites this paper
• The potential of antisense oligonucleotides as a therapy for Duchenne muscular dystrophy in human and canine models of the disease

  2007cites this paper
• Conditionally replicating adenoviruses for cancer treatment.

  2007cites this paper